Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions.

Peters TL, McClain KL, Allen CE.

Mol Ther. 2011 Aug;19(8):1433-9. doi: 10.1038/mt.2011.106. Epub 2011 Jun 7.

2.

Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.

Allen CE, Li L, Peters TL, Leung HC, Yu A, Man TK, Gurusiddappa S, Phillips MT, Hicks MJ, Gaikwad A, Merad M, McClain KL.

J Immunol. 2010 Apr 15;184(8):4557-67. doi: 10.4049/jimmunol.0902336. Epub 2010 Mar 10.

3.

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.

Milne P, Bigley V, Bacon CM, Néel A, McGovern N, Bomken S, Haniffa M, Diamond EL, Durham BH, Visser J, Hunt D, Gunawardena H, Macheta M, McClain KL, Allen C, Abdel-Wahab O, Collin M.

Blood. 2017 Jul 13;130(2):167-175. doi: 10.1182/blood-2016-12-757823. Epub 2017 May 16.

PMID:
28512190
4.

Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions.

Allen CE, McClain KL.

Nat Med. 2009 May;15(5):483-4; author reply 484-5. doi: 10.1038/nm0509-483. No abstract available.

5.

Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion.

Coury F, Annels N, Rivollier A, Olsson S, Santoro A, Speziani C, Azocar O, Flacher M, Djebali S, Tebib J, Brytting M, Egeler RM, Rabourdin-Combe C, Henter JI, Arico M, Delprat C.

Nat Med. 2008 Jan;14(1):81-7. Epub 2007 Dec 23.

PMID:
18157139
6.

Polyclonal T-cells express CD1a in Langerhans cell histiocytosis (LCH) lesions.

West JA, Olsen SL, Mitchell JM, Priddle RE, Luke JM, Akefeldt SO, Henter JI, Turville C, Kannourakis G.

PLoS One. 2014 Oct 24;9(10):e109586. doi: 10.1371/journal.pone.0109586. eCollection 2014.

7.

Gene expression analysis of dendritic/Langerhans cells and Langerhans cell histiocytosis.

Rust R, Kluiver J, Visser L, Harms G, Blokzijl T, Kamps W, Poppema S, van den Berg A.

J Pathol. 2006 Aug;209(4):474-83.

PMID:
16718746
8.

Detection of IL-17A-producing peripheral blood monocytes in Langerhans cell histiocytosis patients.

Lourda M, Olsson-Åkefeldt S, Gavhed D, Björnfot S, Clausen N, Hjalmars U, Sabel M, Tazi A, Aricò M, Delprat C, Henter JI, Svensson M.

Clin Immunol. 2014 Jul;153(1):112-22. doi: 10.1016/j.clim.2014.04.004. Epub 2014 Apr 15.

PMID:
24743018
9.

Differentiation of Langerhans cells in Langerhans cell histiocytosis.

Geissmann F, Lepelletier Y, Fraitag S, Valladeau J, Bodemer C, Debré M, Leborgne M, Saeland S, Brousse N.

Blood. 2001 Mar 1;97(5):1241-8.

10.

IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy.

Murakami I, Morimoto A, Oka T, Kuwamoto S, Kato M, Horie Y, Hayashi K, Gogusev J, Jaubert F, Imashuku S, Al-Kadar LA, Takata K, Yoshino T.

Virchows Arch. 2013 Feb;462(2):219-28. doi: 10.1007/s00428-012-1360-6. Epub 2012 Dec 27.

PMID:
23269323
11.

Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis.

Murakami I, Matsushita M, Iwasaki T, Kuwamoto S, Kato M, Nagata K, Horie Y, Hayashi K, Imamura T, Morimoto A, Imashuku S, Gogusev J, Jaubert F, Takata K, Oka T, Yoshino T.

Cell Commun Signal. 2015 Feb 22;13:13. doi: 10.1186/s12964-015-0092-z. Review.

12.

Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?

Berres ML, Merad M, Allen CE.

Br J Haematol. 2015 Apr;169(1):3-13. doi: 10.1111/bjh.13247. Epub 2014 Nov 28. Review.

13.

Langerhans cells (CD1a and CD207), dermal dendrocytes (FXIIIa) and plasmacytoid dendritic cells (CD123) in skin lesions of leprosy patients.

Hirai KE, Aarão TL, Silva LM, de Sousa JR, de Souza J, Dias LB Jr, Carneiro FR, Fuzii HT, Quaresma JA.

Microb Pathog. 2016 Feb;91:18-25. doi: 10.1016/j.micpath.2015.11.013. Epub 2015 Nov 27.

PMID:
26639680
14.

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.

Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, Beltrão M, Lira SA, Heym KM, Bigley V, Collin M, Manz MG, McClain K, Merad M, Allen CE.

J Exp Med. 2014 Apr 7;211(4):669-83. doi: 10.1084/jem.20130977. Epub 2014 Mar 17. Erratum in: J Exp Med. 2015 Feb 9;212(2):281.

15.

IL-17A in LCH: systemic biomarker, local factor, or none of the above?

Hogarty MD.

Mol Ther. 2011 Aug;19(8):1405-6. doi: 10.1038/mt.2011.150. No abstract available.

16.

Differences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease.

da Costa CE, Egeler RM, Hoogeboom M, Szuhai K, Forsyth RG, Niesters M, de Krijger RR, Tazi A, Hogendoorn PC, Annels NE.

J Pathol. 2007 Jun;212(2):188-97.

PMID:
17447723
17.

Coexpression of CD1a, langerin and Birbeck's granules in Langerhans cell histiocytoses (LCH) in children: ultrastructural and immunocytochemical studies.

Dziegiel P, Dolilńska-Krajewska B, Dumańska M, Wecławek J, Jeleń M, Podhorska-Okołów M, Jagoda E, Fic M, Zabel M.

Folia Histochem Cytobiol. 2007;45(1):21-5.

18.

Activated Conventional T-Cells Are Present in Langerhans Cell Histiocytosis Lesions Despite the Presence of Immune Suppressive Cytokines.

Quispel WT, Stegehuis-Kamp JA, Santos SJ, Egeler RM, van Halteren AG.

J Interferon Cytokine Res. 2015 Oct;35(10):831-9. doi: 10.1089/jir.2014.0190. Epub 2015 Sep 18.

PMID:
26381039
20.

[Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical analysis of 258 cases].

Xu X, Liu WP, Yang QP, Wang WY, Liao DY, Zhao S, Bi CF, Lin L, Min M.

Zhonghua Bing Li Xue Za Zhi. 2012 Feb;41(2):91-6. Chinese.

PMID:
22455884

Supplemental Content

Support Center